Article Text
Correction
Correction: Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
Statistics from Altmetric.com
Karunaratne K, Ahrabian D, Monoghan B, et al. Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. BMJ Neurol Open 2021;3:e000096. doi:10.1136/bmjno-2020-000096
The article has been corrected since it was first published. The published version misspelled one of the authors’ names as ‘Bernadette Monoghan’ which has been now amended to ‘Bernadette Monaghan’.